AZN
Price
$81.70
Change
-$0.08 (-0.10%)
Updated
Sep 5 closing price
Capitalization
251.96B
59 days until earnings call
SNYNF
Price
$92.30
Change
+$0.49 (+0.53%)
Updated
Sep 5 closing price
Capitalization
112.96B
Interact to see
Advertisement

AZN vs SNYNF

Header iconAZN vs SNYNF Comparison
Open Charts AZN vs SNYNFBanner chart's image
AstraZeneca
Price$81.70
Change-$0.08 (-0.10%)
Volume$2.46M
Capitalization251.96B
Sanofi
Price$92.30
Change+$0.49 (+0.53%)
Volume$301.49K
Capitalization112.96B
AZN vs SNYNF Comparison Chart in %
Loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZN vs. SNYNF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a Hold and SNYNF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (AZN: $81.70 vs. SNYNF: $92.30)
Brand notoriety: AZN: Notable vs. SNYNF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 55% vs. SNYNF: 0%
Market capitalization -- AZN: $251.96B vs. SNYNF: $112.96B
AZN [@Pharmaceuticals: Major] is valued at $251.96B. SNYNF’s [@Pharmaceuticals: Major] market capitalization is $112.96B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $651.91B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $89.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 1 FA rating(s) are green whileSNYNF’s FA Score has 1 green FA rating(s).

  • AZN’s FA Score: 1 green, 4 red.
  • SNYNF’s FA Score: 1 green, 4 red.
According to our system of comparison, AZN is a better buy in the long-term than SNYNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 2 TA indicator(s) are bullish while SNYNF’s TA Score has 6 bullish TA indicator(s).

  • AZN’s TA Score: 2 bullish, 5 bearish.
  • SNYNF’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SNYNF is a better buy in the short-term than AZN.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а +2.25% price change this week, while SNYNF (@Pharmaceuticals: Major) price change was -7.97% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.16%. For the same industry, the average monthly price growth was +3.97%, and the average quarterly price growth was +10.41%.

Reported Earning Dates

AZN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.16% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZN($252B) has a higher market cap than SNYNF($113B). AZN has higher P/E ratio than SNYNF: AZN (30.77) vs SNYNF (15.37). AZN YTD gains are higher at: 27.355 vs. SNYNF (-2.943). AZN has higher annual earnings (EBITDA): 16.8B vs. SNYNF (12.6B). SNYNF has more cash in the bank: 15.4B vs. AZN (7.11B). SNYNF has less debt than AZN: SNYNF (22.3B) vs AZN (32.8B). AZN has higher revenues than SNYNF: AZN (56.5B) vs SNYNF (45.7B).
AZNSNYNFAZN / SNYNF
Capitalization252B113B223%
EBITDA16.8B12.6B133%
Gain YTD27.355-2.943-930%
P/E Ratio30.7715.37200%
Revenue56.5B45.7B124%
Total Cash7.11B15.4B46%
Total Debt32.8B22.3B147%
FUNDAMENTALS RATINGS
AZN vs SNYNF: Fundamental Ratings
AZN
SNYNF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
34100
SMR RATING
1..100
4560
PRICE GROWTH RATING
1..100
4980
P/E GROWTH RATING
1..100
8095
SEASONALITY SCORE
1..100
6565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNYNF's Valuation (4) in the null industry is in the same range as AZN (23) in the Pharmaceuticals Major industry. This means that SNYNF’s stock grew similarly to AZN’s over the last 12 months.

AZN's Profit vs Risk Rating (34) in the Pharmaceuticals Major industry is significantly better than the same rating for SNYNF (100) in the null industry. This means that AZN’s stock grew significantly faster than SNYNF’s over the last 12 months.

AZN's SMR Rating (45) in the Pharmaceuticals Major industry is in the same range as SNYNF (60) in the null industry. This means that AZN’s stock grew similarly to SNYNF’s over the last 12 months.

AZN's Price Growth Rating (49) in the Pharmaceuticals Major industry is in the same range as SNYNF (80) in the null industry. This means that AZN’s stock grew similarly to SNYNF’s over the last 12 months.

AZN's P/E Growth Rating (80) in the Pharmaceuticals Major industry is in the same range as SNYNF (95) in the null industry. This means that AZN’s stock grew similarly to SNYNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNSNYNF
RSI
ODDS (%)
Bearish Trend 3 days ago
40%
Bullish Trend 3 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
40%
Bullish Trend 3 days ago
53%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
59%
MACD
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
56%
Bearish Trend 3 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
55%
Bearish Trend 3 days ago
47%
Advances
ODDS (%)
Bullish Trend 5 days ago
55%
Bullish Trend 21 days ago
49%
Declines
ODDS (%)
Bearish Trend 3 days ago
43%
Bearish Trend 28 days ago
51%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
47%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 3 days ago
52%
Bullish Trend 3 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFGC105.420.17
+0.16%
Performance Food Group Company
SKK0.41N/A
N/A
SKK Holdings Ltd
VIAV11.66-0.07
-0.60%
Viavi Solutions
CASS43.04-0.39
-0.90%
Cass Information Systems
COYA6.27-0.11
-1.72%
Coya Therapeutics

AZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZN has been loosely correlated with GSK. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if AZN jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZN
1D Price
Change %
AZN100%
-0.10%
GSK - AZN
63%
Loosely correlated
+2.25%
NVS - AZN
61%
Loosely correlated
+1.02%
SNY - AZN
50%
Loosely correlated
+2.58%
AZNCF - AZN
48%
Loosely correlated
+1.54%
PFE - AZN
47%
Loosely correlated
+1.39%
More

SNYNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNYNF has been loosely correlated with SNY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SNYNF jumps, then SNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYNF
1D Price
Change %
SNYNF100%
+0.54%
SNY - SNYNF
37%
Loosely correlated
+2.58%
NVSEF - SNYNF
24%
Poorly correlated
N/A
AZN - SNYNF
23%
Poorly correlated
-0.10%
JNJ - SNYNF
22%
Poorly correlated
-0.18%
NVS - SNYNF
21%
Poorly correlated
+1.02%
More